Beyond ECMO Survival: Long-Term Symptom Burden and Quality-of-Life Impairment in Hantavirus Cardiopulmonary Syndrome Survivors
| dc.article.number | 1241 | |
| dc.catalogador | grr | |
| dc.contributor.author | Valenzuela Galaz, Gonzalo Hernan | |
| dc.contributor.author | Barahona, Katherine | |
| dc.contributor.author | Rojas, Camila | |
| dc.contributor.author | Barrera, Aldo | |
| dc.contributor.author | Henríquez, Carolina | |
| dc.contributor.author | Martínez-Valdebenito, Constanza | |
| dc.contributor.author | Potin, Marcela | |
| dc.contributor.author | Bedregal, Paula | |
| dc.contributor.author | Ferrés, Marcela | |
| dc.date.accessioned | 2025-09-24T19:35:30Z | |
| dc.date.available | 2025-09-24T19:35:30Z | |
| dc.date.issued | 2025 | |
| dc.description.abstract | Andes virus (ANDV) is the leading cause of hantavirus cardiopulmonary syndrome (HCPS) in South America, a severe zoonosis with high mortality. Advances in critical care and extracorporeal membrane oxygenation (ECMO) have significantly improved survival rates; however, data on recovery beyond survival remain limited. This multicenter cohort study enrolled laboratory-confirmed HCPS survivors in Chile between 2021 and 2024, with follow-up at 3–6 months post-symptom onset to assess physical and neuropsychological sequelae. Participants were stratified by ECMO requirement and the clinical severity of HCPS, and evaluated using self-reported recovery, standardized symptom questionnaires, and EQ-5D quality-of-life instruments. Among 21 survivors (11 ECMO, 10 non-ECMO), 61.9% reported incomplete recovery. While 60–70% of patients received general medical follow-up, only 30% of non-ECMO patients—compared to all ECMO patients—had contact with a rehabilitation provider. Motor dysfunction and palpitations were more frequent in ECMO survivors; however, Jaccard index analysis revealed clustering of physical and neuropsychological symptoms across both groups. EQ-5D assessments showed comparable quality-of-life impairment, though non-ECMO survivors more often reported pain/discomfort (90.0% vs. 63.6%) and higher rates of analgesic self-medication. These findings highlight the burden of persistent symptoms after HCPS and the need for multidisciplinary post-discharge care in endemic regions. | |
| dc.fechaingreso.objetodigital | 2025-09-24 | |
| dc.format.extent | 15 páginas | |
| dc.fuente.origen | ORCID | |
| dc.identifier.doi | 10.3390/v17091241 | |
| dc.identifier.issn | 1999-4915 | |
| dc.identifier.uri | https://doi.org/10.3390/v17091241 | |
| dc.identifier.uri | https://repositorio.uc.cl/handle/11534/105750 | |
| dc.information.autoruc | Departamento de Salud Pública, Escuela de Medicina; Bedregal, Paula; 0000-0003-3550-9117; 79369 | |
| dc.information.autoruc | Escuela de Medicina; Valenzuela Galaz, Gonzalo Hernan; 0000-0002-5538-8749; 213128 | |
| dc.issue.numero | 9 | |
| dc.language.iso | en | |
| dc.nota.acceso | contenido completo | |
| dc.revista | Viruses | |
| dc.rights | acceso abierto | |
| dc.rights.license | CC BY 4.0 Attribution 4.0 International | |
| dc.rights.uri | https://creativecommons.org/licenses/by/4.0/deed.en | |
| dc.subject | Hantaviridae | |
| dc.subject | Hantavirus cardiopulmonary syndrome | |
| dc.subject | Rodent-borne viruses | |
| dc.subject | Post-acute sequela | |
| dc.subject | Long-term symptoms | |
| dc.subject | Zoonosis | |
| dc.subject | Virus–host interaction | |
| dc.subject | Extracorporeal membrane oxygenation | |
| dc.subject.ddc | 610 | |
| dc.subject.dewey | Medicina y salud | es_ES |
| dc.subject.ods | 03 Good health and well-being | |
| dc.subject.odspa | 03 Salud y bienestar | |
| dc.title | Beyond ECMO Survival: Long-Term Symptom Burden and Quality-of-Life Impairment in Hantavirus Cardiopulmonary Syndrome Survivors | |
| dc.type | artículo | |
| dc.volumen | 17 | |
| sipa.codpersvinculados | 213128 | |
| sipa.codpersvinculados | 79369 |
